Home

Study doubts MS drug

2000-01-27T00:00:00

Money would be better spent on alternative ways of improving quality of life in people with secondary progressive multiple sclerosis than on the drug beta interferon, according to research conducted in Scotland.

You need to be a subscriber to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All HSJ news by sector, topic & region
  • Breaking News announcements
  • App for mobile and offline reading
  • Comment and Daily Insights newsletters
  • Regional roundup newsletters
  • 10 expert briefings every fortnight (Premium only)
  • Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant (Premium only)

Subscribe

to HSJ

Already a subscriber? Sign into your account here